MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Model Number ESBF2814C103EE |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Fever (1858)
|
Event Date 03/28/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: e tlw1620c156ee, serial/lot #: (b)(6), ubd: 08-feb-2026, udi#: (b)(4) ; product id: etlw1616c156ee, serial/lot #: (b)(6), ubd: 20-dec-2025, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
An endurant ii/iis stent graft was implanted as part of the advance study for the treatment of an abdominal aortic aneurysm.It was reported that the day after the procedure, the patient experienced fever symptoms of 39.5 °c.The reported fever required prolonged hospitalization and blood cultures were taken.The patient recovered on (b)(6) 2023 and was discharged with a normal temperature of 37.3 °c.The results of the blood culture showed no growth of bacteria.The site assessed the fever as having a possibly related to the index procedure, while the site assessed as probably related to the index procedure.The site and sponsor assessed the fever as possibly related to the study device and not related to an underlying condition or disease.Both stated that implant of evar could cause post operative fever.No additional clinical sequalae were provided and the patient is fine.
|
|
Manufacturer Narrative
|
B5; additional information received; the site and sponsor have now assessed the fever as not related to the study device.The sponsor assessed the fever as causally related to the index procedure.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|